Which radionuclide, carrier molecule and clinical indication for alpha-immunotherapy? - Archive ouverte HAL Access content directly
Journal Articles The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutic Year : 2015

Which radionuclide, carrier molecule and clinical indication for alpha-immunotherapy?

(1) , (2) , (3) , (1) , (4, 1) , (2, 1)
1
2
3
4
Not file

Dates and versions

hal-02415080 , version 1 (16-12-2019)

Identifiers

  • HAL Id : hal-02415080 , version 1

Cite

François Guérard, Jacques Barbet, Ferid Haddad, Michel Cherel, Francoise Kraeber-Bodere, et al.. Which radionuclide, carrier molecule and clinical indication for alpha-immunotherapy?. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutic, 2015. ⟨hal-02415080⟩
59 View
0 Download

Share

Gmail Facebook Twitter LinkedIn More